for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Myomo Inc

MYO

Latest Trade

0.79USD

Change

0.01(+1.02%)

Volume

45,360

Today's Range

0.73

 - 

0.79

52 Week Range

0.61

 - 

2.69

As of on the NYSE MKT LLC ∙ Minimum 15 minute delay

Pricing

Previous Close
0.78
Open
0.78
Volume
45,360
3M AVG Volume
5.60
Today's High
0.79
Today's Low
0.73
52 Week High
2.69
52 Week Low
0.61
Shares Out (MIL)
17.14
Market Cap (MIL)
13.38
Forward P/E
-1.25
Dividend (Yield %)
--

Next Event

Myomo Inc at Sidoti & Company Fall Conference

Latest Developments

More

Myomo Reports Q2 Loss Per Share $0.15

Myomo Reports Q1 Loss Per Share Of $0.17

Myomo Reports Fourth Quarter And Year End 2018 Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Myomo Inc

Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.

Industry

Medical Equipment & Supplies

Contact Info

1 Broadway Fl 14

+1.617.9969058

http://myomo.com/

Executive Leadership

Steve Kelly

Founder, Chairman of the Board, President and Chief Operating Officer

Paul R. Gudonis

Chief Executive Officer, Director

David A. Henry

Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer

Jonathan Naft

General Manager - O&P

Fredrick Nahm

Medical Director

Key Stats

2.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2017

-2.930

2018

-0.840

2019(E)

-0.627
Price To Earnings (TTM)
--
Price To Sales (TTM)
4.17
Price To Book (MRQ)
1.88
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-112.94
Return on Equity (TTM)
-97.23

Latest News

BRIEF-Myomo Says CMS Published Favorable Prelim Decision Regarding Application For Medicare Codes

* MYOMO - CMS PUBLISHED FAVORABLE PRELIMINARY DECISION REGARDING APPLICATION FOR HEALTHCARE COMMON PROCEDURE CODING SYSTEM "L" CODES Source text for Eikon: Further company coverage:

BRIEF-Myomo Q1 Loss Per Share $0.20

* Q1 REVENUE ROSE 45 PERCENT TO $313,000 Source text for Eikon: Further company coverage:

BRIEF-Myomo Inc - Qtrly Loss Per Share $0.25

* MYOMO INC - QTRLY LOSS PER SHARE $0.25 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Myomo Q4 Loss Per Share $0.25

* Q4 REVENUE ROSE 22 PERCENT TO $547,000 Source text for Eikon: Further company coverage:

BRIEF-CVI Investments Inc Reports A 6.1 Pct Passive Stake In Myomo

* CVI INVESTMENTS INC REPORTS A 6.1 PCT PASSIVE STAKE IN MYOMO INC AS OF NOV 30 - SEC FILING Source text: (http://bit.ly/2y8iUcV) Further company coverage:

BRIEF-Empery Asset Management Lp​ Reports A 9.93 Percent Passive Stake In Myomo Inc As Of November 30

* EMPERY ASSET MANAGEMENT LP REPORTS A 9.93 PERCENT PASSIVE STAKE IN MYOMO INC AS OF NOVEMBER 30 - SEC FILING Source text (http://bit.ly/2jNQf87) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-Sabby Management LLC Reports A 5.54 Pct Passive Stake In Myomo Inc

* SABBY MANAGEMENT LLC REPORTS A 5.54 PCT PASSIVE STAKE IN MYOMO INC AS OF NOV 30 - SEC FILING Source text: (http://bit.ly/2A0npMv) Further company coverage:

BRIEF-Myomo Inc Announces Pricing Of Public Offering

* MYOMO - PRICED PUBLIC OFFERING OF 4,175,000 SHARES OF ITS COMMON STOCK AND ACCOMPANYING WARRANTS TO PURCHASE 4,175,000 SHARES OF COMMON STOCK

BRIEF-Myomo files registration statement for proposed follow-on offering

* Myomo, Inc. files registration statement for proposed follow-on offering

BRIEF-Myomo Q3 loss per share $0.21

* Q3 revenue rose 165 percent to $489,000 Source text for Eikon: Further company coverage:

BRIEF-Myomo Inc - ‍announced application for a canadian medical device license approved by Health Canada​

* Myomo Inc - announced that its application for a canadian medical device license has been approved by Health Canada

BRIEF-Myomo Inc files for offering of up to $6 million

* Myomo Inc files for offering of up to $6 million - SEC filing Source text: (http://bit.ly/2xUgOxm) Further company coverage:

BRIEF-Myomo reports Q2 loss per share $3.35

* Q2 revenue rose 21 percent to $307,000 Source text for Eikon: Further company coverage:

BRIEF-Myomo Inc obtains CE mark approval for Myopro

* Has obtained CE mark approval for commercial sale of its Myopro Myoelectric arm orthosis across European economic area Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up